Back to compounds

COMPOUND PROFILE / PEPTIDES & ANALOGUES

Semax.

Research draft

Semax is an ACTH-fragment-derived synthetic peptide studied in neurological contexts.

Keep the context.

Research evidence and COA results do not establish suitability for use. This is educational information, not a dosing guide or personal medical advice.

Targeted source and identity review, not a systematic review or complete regulatory audit.

Overview

Semax is an ACTH-fragment-derived synthetic peptide studied in neurological contexts.

CLASSIFICATIONPeptides & analogues
MOLECULAR / SEQUENCE INFO7 amino acids
PRIMARY CONTEXTACTH fragment analogue

Mechanism

Experimental work examines neurotrophic and inflammatory signalling; it should not be described as ordinary ACTH.

Human research

Regional human stroke-related studies exist, but study design and independent replication limit wider conclusions.

Preclinical & other research

Animal and cell work examines injury-response and gene-expression pathways.

Safety & unknowns

Route, population and product differences prevent broad long-term safety claims.

Regulatory status

Local medicine status must be checked; regional clinical use does not establish universal approval.

Reported use & evidence

Research profile draft

The supplied Semax profile and its cited sources are imported. Community experiences and laboratory evidence remain separate from these descriptions. Missing evidence is not a zero result.

Sources & references

Explore more compounds